Parkinsons Disease Treatment Market: Carbidopa/Levodopa Segment is Accounted for the Largest Share
Parkinson’s disease treatment is used to treat the symptoms of Parkinson’s disease, generally, medication is the first line treatment for this disease. The global Parkinsons disease treatment market is expected to reach USD 5.69 billion by 2022 from USD 4.24 billion in 2017, at a CAGR of 6.1% . Rising geriatric population and government funding for research on Parkinson’s disease are the driving factors for this market. Currently, a wide range of treatments is available for alleviating the symptoms of Parkinson’s disease. Medication is the first line therapy for treating the disease; however, they are not effective in all stages of the disease. In the severe stages, medications do not show pharmacological action in relieving disease symptoms. Neurologists perform thalamotomy, pallidotomy, or implant deep brain stimulation (DBS) devices in order to ease symptoms. Moreover, the focus on gene therapy research has increased. According to the Parkinson’s Disease...